LOGIN
Imrecoxib vs. Celecoxib for Pain Control After Arthroscopic Knee Surgery
July 2022
Imrecoxib vs. Celecoxib for Pain Control After Arthroscopic Knee Surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Imrecoxib versus celecoxib as postoperative analgesia for patients receiving arthroscopic knee surgery: a randomized, controlled, non-inferiority study
Inflammopharmacology. 2022 Jun;30(3): 875-881.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and twenty-six patients undergoing arthroscopic knee surgery were randomized in this non-inferiority trial to receive either imrecoxib (n=64) or celecoxib (n=62). The primary outcome of interest pain scores on a Visual Analog Scale (VAS), measured at rest and during movement up to 72 hours post-operation. Secondary outcomes of interest included pethidine administration, patient satisfa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.